作者
Parastoo Yousefi, Saber Soltani, Goli Siri, Sara Akhavan Rezayat, Ali Gholami, Alireza Zafarani, Mohamad Hossein Razizadeh, Ehsan Alborzi, Golnaz Mokhtary‐Irani, Behnam Abedi, Sajad Karampoor, Alireza Tabibzadeh, Abbas Farahani
发表日期
2023/6
来源
Journal of Clinical Laboratory Analysis
卷号
37
期号
11-12
页码范围
e24941
简介
During 2019, the SARS‐CoV‐2 emerged from China, and during months, COVID‐19 spread in many countries around the world. The expanding data about pathogenesis of this virus could elucidate the exact mechanism by which COVID‐19 caused death in humans. One of the pathogenic mechanisms of this disease is coagulation. Coagulation disorders that affect both venous and arterial systems occur in patients with COVID‐19. The possible mechanism involved in the coagulation could be excessive inflammation induced by SARS‐CoV‐2. However, it is not yet clear well how SARS‐CoV‐2 promotes coagulopathy. However, some factors, such as pulmonary endothelial cell damage and some anticoagulant system disorders, are assumed to have an important role. In this study, we assessed conducted studies about COVID‐19‐induced coagulopathy to obtain clearer vision of the wide range of manifestations …
引用总数
学术搜索中的文章